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The patients had received intravenous infusions of ritodrine
hydrochloride for tocolysis. Patients with complications such as
hypertensive disorders of pregnancy, cardiac malformations, or
severe anemia were excluded. All patients were in sinus rhythm
and had normal cardiac function.
In Study 2 (June 2015-June 2016), we enrolled 15 pregnant
women without complications (Table 1). The patients underwent
labor at term that was either induced by (or augmented with)
oxytocin or spontaneous. The infusion volume was limited to only
the amount necessary to induce/augment labor, or it was not
administered. Patients were excluded if they required additional
treatment, such as infusion for atonic bleeding or magnesium
sulfate for hypertensive disorders of pregnancy. Oxytocin was
initiated concurrently with the start of induction or weak labor pain.
Our hospital -based oxytocin protocol was used for all patients ;
this started with 1.7 mU/min and then increased by 1.7 mU
every 30 min until regular uterine contractions occurred. The
maximum dose of oxytocin was 20 mU, with no limit to the length of
time a patient could remain at 20 mU. When the oxytocin infusion
was continued after umbilical cord clamping, it was administered at
the same dose.
Echocardiography
All measurements were obtained with the patient resting in the
left lateral position to optimize TTE imaging. An experienced
cardiac sonographer starting monitoring CO with both TTE and
EC within 10 min after the start of TTE. TTE was performedusing
an echocardiographic Doppler system (Vivid E9 ; GE Healthcare,
Chalfont St. Giles, UK). Measurements and recordings were
obtained according to the recommendations of the American
Society of Echocardiography (8). CO was determined by Doppler
echocardiographic measurement of the left ventricular outflow
tract (LVOT) velocity combined with the cross-sectional area with
measurement of the LVOT diameter. The flow velocity was meas-
ured with pulsed-wave Doppler echocardiography by placing a
transducer on the apex. An average of 8 to 10 consecutive beats was
used for each determination. The diameter of the LVOT was
measured during systole from a cross-sectional echocardiographic
view (parasternal long-axis plane). Diameters from five consecutive
beats were averaged.
The LVOT cross-sectional area was calculated from the equation
(D/2)2π, where D is the mean LVOT diameter. Heart rate (HR) was
determined from the R-R interval of a simultaneously recorded
electrocardiogram. CO was then calculated according to the follow-
ing formula : CO (ml/min) = stroke volume (SV) (ml) × HR (/min),
where SV (ml) is calculated as time velocity integral (cm) × cross-
sectional area (cm2). End-systolic and end-diastolic dimensions
were measured from standard left ventricular M-mode echocar-
diographs. Based on these algorithms, CO was measured by TTE
(TTE-CO).
Electricalcardiometry
EC is based on a bioimpedance technique that is used to measure
changes in transthoracic impedance during cardiac ejection caused
by volumetric changes of the aorta. We used an AESCULON Mini
(Osypka Medical GmbH, Berlin, Germany) for EC. Four dispos-
able electrocardiographic electrodes were attached at the neck and
the inferior aspect of the thorax at the level of the xiphoid process to
record the changing impedance over that area of the thorax. A high-
frequency (50-kHz), low-amperage (2-mA) alternating electrical
current of constant amplitude was emitted via a pair of surface
electrodes across the left thorax. The inner electrodes acted as
sensing electrodes to register electrical resistance changes caused
by application of the current and recorded the thoracic electrical
bioimpedance (Z).
Z= sensed voltageapplied current
Verification of the correct signal quality was accomplished by
visualizing the electrocardiogram, the impedance waveform, and
its first derivative. The maximum rate of change in the thoracic
electrical bioimpedance over that area was interpreted as the
ohmic equivalent of the mean blood flow velocity in the ascending




where VEPT (ml) is the volume of electrically participating tissue
derived from the body mass and height, ν (/s) is the ohmic
equivalent of the mean aortic blood flow velocity during left ven-
tricular ejection, and LVET (s) is the left ventricular ejection time.
The impedance recordings and CO and SV calculations were
obtained using the AESCULON Mini, incorporating an algorithm
that transforms the ohmic equivalent of mean aortic blood flow
acceleration into an equivalent of mean aortic blood flow velocity :
ν=[(dZ(t)/dt)minZ0 ]n
where [(dZ(t)/dt) min] is the maximum rate of change of the
thoracic electrical bioimpedance during systole and Z0 is the base
impedance (average value over 10 cardiac cycles). Based on these
algorithms, EC was used to measure CO (EC-CO).
Protocol for Study 1
Each TTE measurement was paired with the EC measurement
that most closely followed it in time, and only TTE and EC data pairs
measured within 20 s of each other were included. This resulted in
multiple data pairs for each patient ; these pairs were then aver-
aged to obtain one value per patient for each variable. The average
values were used for statistical analysis. The closest EC measure-
ment following the velocity-time integral image was chosen because
EC data were acquired as the moving average of the previous 10
heartbeats, whereas TTE data reflect one velocity-time integral
image obtained at a single instant in time. This explicit pairing of EC
and TTE measurements was initially performed to compare all
paired EC and TTE measurement sets individually for a given
patient. However, we later decided to report one average valueper
patient for each technology.
Protocol for Study 2
We set up the AESCULONMini for each patient at the begin-
Table1. Biometric data
Study 1 Study 2
Age, years 30.4 ± 5.7 33.9 ± 4.3
Height, cm 161.2 ± 21.1 156.9 ± 6.2
Weight, kg 61.9 ± 10.5 66.0 ± 9.9
Heart rate, beats/min 87.6 ± 34.1 
Systolic blood pressure, mmHg 107.6 ± 43.4 116.1 ± 10.2*
Diastolic blood pressure, mmHg 61.5 ± 31.5 69.1 ± 10.5*
Gestational age, weeks 30.1 ± 8.6 39.0 ± 1.0
Rate of oxytocin use, %  47.7
Delivery time, hours  5.9 ± 4.1
Amount of bleeding during
delivery, g  259.4 ± 94.6
Birth weight, g  3133.6 ± 339.8
Data are presented as meanstandard deviation.
Physical data correspond to the time of delivery (except for the rate of
oxytocin use, which is presented as the percentage of the total number
of patients).
*Immediately after delivery.
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ning of labor to measure hemodynamics. HR, SV, and CO were
measured in beat- to-beat mode. All patients were maintained in
the dorsal lithotomy position during delivery and in the supine
position after delivery. The measurements were obtained at prede-
fined time points : labor onset, newborn delivery, and at 10, 15, 20,
30, 60, 90, and 120 min after delivery. Measurement at labor onset
was performed during an intermittent period during uterine con-
tractions. Hemodynamic data were stored in the AESCULON Mini
monitor and downloaded as text files.
Statistical analysis
For Study 1, the correlation between TTE-CO and EC-CO values
was evaluated by calculating Pearson’s correlation coefficient r and
applying a linear regression model of TTE-CO on EC-CO. The
spread of the slope and the ordinate of this relationship were
expressed as a standard error. The correlation coefficient was then
calculated to allow comparison of our results with those of other
studies. The differences between the paired CO values were also
plotted against the average CO values of both measurements. This
statistical method was recommended by Bland−Altman for evalu-
ation studies. To investigate the relationship between the measure-
ment error and the true value, the values were plotted as the
difference between the methods and their means. The limits of
agreement were estimated by calculating the mean difference
(bias) and standard deviation (SD). The upper and lower limits
were defined as the bias2 SD, the range in which 95% of the
differences between the methods were expected to occur. A P
value of0.05 was considered to indicate statistical significance.
For Study 2, the Wilk-Shapiro test was used to assess the nor-
mality of the distribution of data. All continuous, normally distrib-
uted measurements are presented as meanSD. Categorical
data are reported as median with interquartile range. Comparisons
of hemodynamic variables from labor onset and newborn deliv-
ery to the other predefined time points were performed using
analysis of variance with repeated measures. All data were ana-
lyzed using EZR (Saitama Medical Center, Jichi Medical University,
Saitama, Japan), a graphic user interface for R (The R Foundation
for Statistical Computing, Vienna, Austria) ; EZR is a modified
version of R Commander designed to add statistical functions
frequently used in biostatistics. The significance level was set P
0.05.
RESULTS
Study 1 : Relationships between TTE-CO and EC-CO
In total, 20 patients were enrolled in Study 1. No patients were
removed from the analysis (i.e., TTE-CO andEC-CO values were
obtained for all patients). No serious complications occurred
during the study. The pooled EC-CO was 3.68 to 8.10 L/min, and
TTE-CO was 3.35 to 7.10 L/min. Figure 1 shows a scatter plot of the
data with the linear regression line.
A significant correlation was found between the two methods
(P0.001), with r = 0.79. EC-CO was linearly related to TTE-CO,
with a y- intercept of 1.19 and a line slope of 0.85 (i.e., the EC-CO
values were higher than TTE-CO values). Bland−Altman analysis
data are shown in Figure 2.
The mean difference (bias) between EC-CO and TTE-CO was
0.36 L/min (SD, 0.67 L/min). The limits of agreement were defined
as the mean difference2 SD. The lower and upper limits of
agreement for the comparison of EC-CO with TTE-CO were −0.98
and 1.7 L/min, respectively. The rate of relative errors within20%
was 95% of all measurements.
Fig. 1 Scatter plot comparing cardiac output. This graph denotes the
linear regression line. TTE-CO, cardiac output as measured by transtho-
racic echocardiography ; EC-CO, cardiac output as measured by electrical
cardiometry
Fig. 2 Bland-Altman plot. Bias plot of the difference in cardiac output asmeasured by EC and TTE compared with themean of the two results. The mean
difference in EC-TTE was 0.36 L/min (standard deviation, 0.67 L/min). The lower and upper limits of agreement were -0.98 and 1.7 L/min,
respectively. TTE-CO, cardiac output as measured by transthoracic echocardiography ; EC-CO, cardiac output as measured by electrical
cardiometry
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Study 2 : Hemodynamic changes during and after vaginal delivery
Hemodynamic variables measured at the predefined time points
are shown in Figure 3.
A significant increase in HR, SV, and CO occurred at the time of
newborn delivery compared with the baseline value measured at
the onset of labor. HR, SV, and CO increased by 32.9%, 50.5%, and
95.0% from baseline, respectively. At 10 min after delivery, HR
fell to that observed at labor onset and remained constant. In
contrast, SV and CO at 10 min after delivery decreased from that
seen during newborn delivery, but remained higher than that at
labor onset. SV and CO remained stable until 120 min after deliv-
ery, with values 20.4% and 22.5% higher than those at labor onset,
respectively.
DISCUSSION
We confirmed that EC can be used to evaluate the hemody-
namics of pregnant women, with findings similar to those of TTE.
We also found that a high-CO state persisted for at least 2 h after
vaginal delivery because of the sustained high SV.
The thermodilution method using a pulmonary artery catheter is
the accepted gold standard for evaluation of CO, but this tech-
nique is invasive and risky. Hence, TTE is now generally used
because it is simple and noninvasive. Indeed, TTE is reportedly
useful in pregnant women with the same accuracy as thermodilu-
tion (9). A disadvantage of TTE is that the technique needs to be
learned. Further, the same posture must be maintained for a
prolonged time, which is difficult for pregnant patients. Finally,
TTE cannot be used for continuous measurement. Therefore,
there are some limits to using TTE for evaluation of hemodynamics
in pregnant women, especially during labor and delivery.
In contrast to thermodilution and TTE, EC uses the increase in
conductivity from the change in orientation of red blood cells to
determine the velocity of blood flow, allowing SV and COmeasure-
ment (10). EC is easy to use, and there is no restriction caused by
the position or physique of the patient. Previous studies have
demonstrated that EC is a reliable technique for measuring CO
compared with well -established methods such as the direct Fick’s
oxygen principle, thermodilution, or transesophageal echocar-
diography (11, 12). In obstetrics, EC is also used to measure the
Fig. 3 Circulation fluctuationaround the timeof vaginal delivery. (a)Heart rate. (b)Stroke volume. (c)Cardiac output. Data are presented asmean
(95% confidence limit). The marked groups were considered statistically significant (P0.05) in comparison with *labor onset and †newborn
delivery. Time points : baseline measurement at labor onset (T1), newborn delivery (T2), and after delivery at 10 min (T3), 15 min (T4), 20 min
(T5), 30 min (T6), 60 min (T7), 90 min (T8), and 120 min (T9)
a b
c
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hemodynamic changes associated with cesarean delivery and
oxytocin administration (13, 14). Importantly, EC can provide
continuous and noninvasive measurement without the need for the
operator to undergo a learning curve.
In the present study, EC showed a trend toward higher values
than TTE, although we confirmed the compatibility of the values
measured by the two methods. Grollmuss and Gonzalez (15) also
found that EC produced higher values than TTE. Moreover, TTE
has been shown to underestimate CO compared with magnetic
resonance imaging, which is considered the most accurate nonin-
vasive method for evaluating cardiac function, as in our study
(16-18). Our data support that EC is a useful technique, particu-
larly for continuous evaluation of hemodynamics.
Because EC has been proven feasible for pregnant women as
well as TTE, we attempted to evaluate the hemodynamics around
the time of vaginal delivery using EC. Although dramatic hemody-
namic changes are known to occur during labor, few reports have
focused on detailed hemodynamic measurements around the
delivery period, especially immediately after delivery. Robson et al.
(19) reported that CO increased for at least 1 h after vaginal delivery
because of increased SV, although the HR did not change. By 24 h
after delivery, there were no significant increases in CO, HR, or SV.
However, San-Frutos et al. (20) reported that CO and SV contin-
ued to decline up to 48 h after delivery and then increased com-
pared with these values during early pregnancy. Although both
studies performed evaluations at 48 h after delivery, they did not
evaluate changes around and immediately after delivery, and their
recordings were not continuous. Hemodynamic parameters readily
vary in accordance with factors such as the patient’s posture,
bleeding, pain, and mental state. Therefore, continuous measure-
ment as in the present study is useful for elucidating the maternal
circulation variations that occur during delivery.
It is easy to imagine that hemodynamic parameters change
markedly around vaginal delivery, but whether this actually occurs
remains unknown. Thus, it is important to measure the physiological
hemodynamics of pregnant women. In the present study, HR was
high up to the time of delivery and then rapidly decreased to the
levels observed at the start of labor. The perception of pain and
activation of sympathetic nerves are diminished by labor, which
may explain the HR fluctuation. SV was markedly higher at delivery
and then declined, but remained elevated at 2 h postpartum com-
pared with that at the onset of labor ; thus, high CO also persisted
for at least 2 h after vaginal delivery. This phenomenon may be
caused by a temporary increase in the circulating blood volume,
such as an autologous blood transfusion from the uterus and/or
release of inferior vena cava compression associated with uterine
contractions.
Heart load is an aggravating factor associated with heart disease
and can induce heart failure such as that caused by PPCM. PPCM
often develops during labor to around the time of delivery (21, 22),
and the resulting heart failure can be serious, sometimes even
leading to death. The main pathological condition observed in
PPCM is congestion and low CO. Based on the findings from the
present study, healthy pregnant women have high CO with in-
creasing HR and SV at the time of delivery, and the high-CO state
continues due to high SV. Thus, the heart failure associated with
PPCM may be induced by decreased contractility at a time when it
should inherently respond by increasing CO. EC may be useful for
monitoring circulatory changes in high-risk patients with PPCM.
The present study has three limitations. First, we included only
healthy pregnant women. High-risk patients with complications
were excluded, such as patients with multiple pregnancies, heart
disease, or a hypertensive disorder of pregnancy. The circulatory
dynamics during puerperium in these patients may be different
from those of normal pregnant women. Hemodynamic monitoring
for such high-risk patients is specifically required from the view-
point of the risk of complications, including heart failure and
PPCM. Multiple reports have described the use of EC in non-
pregnant patients with these diseases (23,24). EC has been vali-
dated with acceptable reliability in ill adults (25, 26). Hence, we
suggest that EC can also be used to evaluate hemodynamics in
pregnant women with these complications. Second, the patients in
Study 1 were at preterm gestation and those in Study 2 were at term
gestation. Additionally, ritodrine hydrochloride was used in Study1,
but it was not used in Study 2. Impedance might be differentially
impacted at different gestational ages and with the use of different
drugs. Therefore, the correlation between EC and TTE verified in
Study 1 cannot necessarily be generalized to Study 2. Finally, in
Study 2, we only studied pregnant women who went into labor
without anesthesia and in the Farrar position. Because patient
positioning and anesthesia affect circulation dynamics, our find-
ings may not apply to delivery with patients in other positions and
under anesthesia.
In summary, we confirmed that EC allows for evaluation of
hemodynamic parameters with clinically acceptable accuracy for
pregnant women because of its compatibility with TTE. We also
succeeded in evaluating hemodynamics using EC around the time
of vaginal delivery. We confirmed that CO remained elevated
during labor and immediately after vaginal delivery. Because some
pregnant women may have cardiovascular complications and poor
cardiac function, particular attention should be paid to their post-
partum circulatory dynamics. EC can provide constant monitor-
ing of cardiac function over time ; therefore, we suggest that EC
may support safe delivery management. For high-risk cases,
such as women with hypertensive disorders of pregnancy or cardiac
complications, more careful management is necessary, and hemo-
dynamic monitoring with EC may provide important information.
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